Genetics of apolipoprotein H (β2-glycoprotein I) and anionic phospholipid binding

Abstract

Apolipoprotein H (apoH; also known as β2-glycoprotein I), is an essential cofactor for the binding of certain antiphospholipid antibodies (APA) to anionic phospholipid. The gene coding for apoH is polymorphic, with the occurrence of several common alleles in the general population. This genetically determined variation can effect the binding of apoH to anionic phospholipids and consequently the production of APA. Our group has identified two common mutations at codons 306 (Cys → Gly) and 316 (Trp → Ser) in the fifth domain of apoH which affect the binding of apoH to anionic phospholipids (phosphatidylserine or cardiolipin). ApoH from serum samples homozygous for each of these mutations or compound heterozygotes for both mutations showed no binding with anionic phospholipids on ELISA. In vitro mutagenesis and transient expression of these mutations in COS-1 cells followed by cardiolipin binding studies confirmed that Gly306 and Ser316 are causative mutations. Our data indicate that the fifth domain of apoH is essential for anionic phospholipid binding and genetically determined variation in this domain can affect the production of apoH-dependent APA.

Keywords

apolipoprotein H β2-glycoprotein I anionic phospholipids genetics

Get full access to this article

View all access options for this article.

References

Schultze

, Heide

, Haupt

Uber ein bisher unbekanntes niedermolekulares β₂-globulin des humanserums.

Naturwissenschaften 1961; 48: 719.

Polz

, Kostner

GM.

The binding of β₂-glycoprotein I to human serum lipoproteins.

FEBS Lett 1979; 102: 183–186.

Nakaya

, Schaefer

, Brewer

Jr . Activation of human post heparin lipoprotein lipase by apolipoprotein H (β₂-glycoprotein I). Biochem Biophys Res Commun 1980; 95: 1168–1172.

Lozier

, Takahashi

, Putnam

FW.

Complete amino acid sequence of human plasma β₂-glycoprotein I.

Proc Natl Acad Sci USA 1984; 81: 3640–3644.

Mehdi

. Nucleotide sequence and expression of the human gene encoding apolipoprotein H. Gene 1991; 108: 293–298.

Ichinose

, Bottenus

, Davie

EW.

Structure of transglutaminases.

J Biol Chem 1990; 265: 13411–13414.

Kristensen

. The superfamily of C3b/C4b-binding proteins. Federation Proc 1987; 46: 2463–2469.

Cleve

Genetic studies on the deficiency of β₂-glycoprotein I of human serum.

Humangenetik 1968; 5: 294–304.

McNeil

, Simpson

, Chesterman

, Krilis

SA.

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β₂-glycoprotein I (apolipoprotein H).

Proc Natl Acad Sci USA 1990; 87: 4120–4124.

10.

Galli

. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; i: 1544–1547.

11.

Jones

, James

, Tan

, Mansour

Antiphospholipid antibodies require β₂-glycoprotein I (apolipoprotein H) as cofactor.

J Rheumatol 1992; 19: 1397–1402.

12.

Hunt

. A phospholipid-β₂-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1: 75–81.

13.

Steinkasserer

. Assignment of apolipoprotein H (APOH: β2-glycoprotein I) to human chromosome 17q23 → qter; determination of the major expression site. Cytogenet Cell Genet 1992; 60: 31–33.

14.

Kamboh

, Ferrell

, Sepehrnia

Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (β₂-glycoprotein I).

Am J Hum Genet 1988; 42: 452–457.

15.

Kamboh

, Ferrell

RE.

Apolipoprotein H polymorphism and its role in lipid metabolism.

Adv Lipid Res 1991; 1: 9–18.

16.

Kamboh

, Wagenknecht

DR.

McIntyre J. Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (β₂-glycoprotein I) to anionic phospholipids.

Hum Genet 1995; 95: 385–388.

17.

Sanghera

, Kristensen

, Hamman

, Kamboh

MI.

Molecular basis of the apolipoprotein H (β₂-glycoprotein I) protein polymorphism.

Hum Genet 1997; 100: 57–62.

18.

Steinkasserer

, Dorner

, Wurzner

, Sim

RB.

Human β2-glycoprotein I: molecular analysis of DNA and amino acid polymorphism.

Hum Genet 1993; 91: 401–402.

19.

Wagenknecht

, McIntyre

Changes in β₂-glycoprotein I antigenicity induced by phospholipid binding.

Thromb Haemost 1993; 69: 361–365.

20.

Sanghera

, Waganknecht

, McIntyre

, Kamboh

MI.

Identification of structural mutations in the fifth domain of apolipoprotein H (β₂-glycoprotein I) which affect phospholipid binding.

Hum Mol Genet 1997; 6: 311–316.

21.

Steinkasserer

. Activity, disulphide mapping and structural modelling of the fifth domain of human β₂-glycoprotein I. FEBS Lett 1992; 313: 192–197.

22.

Hunt

, Simpson

, Krilis

SA.

Identification of a region of β₂-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity.

Proc Natl Acad Sci USA 1993; 90: 2141–2145.

23.

Hunt

, Krilis

The fifth domain of β₂-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies.

J Immunol 1994; 152: 653–659.

24.

Sheng

. Site-directed mutagenesis of recombinant human β₂-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol 1996; 157: 3744–3751.